CD4 and HIV-1 infection: In the control group, there was no difference between prevalence of any of HR HPV types alone or in combination according to stages of HIV-1 infection, or CD4+ T cell counts by the time of analysis (WLWH were grouped as having >399, 200–399, <200, or <67 CD4+ T cells per mm3) (Supplementary Table S2; Supplementary Figure S2C).